Drug-Eluting-Stent Market Penetration At Nadir? Rebound Forecast At TCT

U.S. drug-eluting-stent market penetration reached an all-time low in September, but clinicians meeting last week in Washington, D.C., are confident new data will help to reverse the trend that began just over a year ago